Standout Papers
- Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status (2020)
- Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction (2020)
- SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials (2020)
Immediate Impact
62 standout
Citing Papers
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
2024 Standout
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
2024 Standout
Works of Waheed Jamal being referenced
SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
2020 Standout
Evaluation of the Effects of Sodium–Glucose Co-Transporter 2 Inhibition with Empagliflozin on Morbidity and Mortality in Patients with Chronic Heart Failure and a Preserved Ejection Fraction: Rationale for and Design of the EMPEROR-Preserved Trial
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Waheed Jamal | 1492 | 616 | 1347 | 20 | 2.3k | |
| John D. Klemperer | 673 | 805 | 727 | 34 | 2.3k | |
| Christian Landou | 642 | 725 | 937 | 25 | 2.6k | |
| Leanne Dyal | 1262 | 635 | 1867 | 24 | 3.1k | |
| Gösta Dahlén | 946 | 1242 | 842 | 31 | 3.2k | |
| Robin Mukherjee | 860 | 1020 | 1158 | 15 | 2.1k | |
| George Sokos | 1189 | 951 | 1543 | 57 | 3.1k | |
| Rolf Steffensen | 918 | 1041 | 1354 | 60 | 2.6k | |
| Klas Malmberg | 2795 | 709 | 2082 | 15 | 4.1k | |
| Jenifer M. Brown | 1349 | 950 | 798 | 61 | 2.1k | |
| G. Luc | 1410 | 995 | 1300 | 53 | 3.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...